Trisomy 6 in a CML patient receiving imatinib mesylate therapy
Authors:
- Zámečníkova AdrianaZAZámečníkova Adriana
- Al Bahar SoadASAl Bahar Soad
- Ramesh PanditaRPRamesh Pandita
- 30 September 2008
- journal article
- case report
- Published by Elsevier in Leukemia Research
- Vol. 32 (9) , 1454-1457
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylateLeukemia Research, 2007
- Chromosomal abnormalities in Philadelphia chromosome‐negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia in chronic phaseCancer, 2003
- Trisomy 6 acquired in lymphoid blast transformation of chronic myelocytic leukemia with t(9;22)Cancer Genetics and Cytogenetics, 2003
- Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylateLeukemia, 2003
- Emergence of clonal cytogenetic abnormalities in Ph−cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majorityBlood, 2003
- Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia [letter]Blood, 1991